Phenytoin: A Guide to Therapeutic Drug Monitoring
Proceedings of Singapore Healthcare · 2013-09 · 22 (3) · 198-202
DOI: 10.1177/201010581302200307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of Singapore Healthcare, online erschienen am 01.09.2013. Verfasst von Melissa Faye Wu und 1 weiteren Autor:innen. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Therapeutic drug monitoring of phenytoin is carried out to ensure effective and safe levels. Some of the factors complicating phenytoin dosing include a narrow therapeutic window, high degree of protein binding, and nonlinear pharmacokinetics. However, serum drug levels should only be taken when there is a clear indication to guide patient management. Scenarios where monitoring levels may be clinically useful include: (1) establishing an individual therapeutic concentration, (2) aiding in diagnosis of clinical toxicity, (3) assessing patient compliance, and (4) guiding dosage adjustments in patients likely to have greater pharmacokinetic variability. This paper aims to provide an overview on of the correct timing and interpretation of phenytoin levels. It will also address phenytoin dosing, other monitoring parameters, and management of phenytoin adverse effects.
Zitieren
APA
Wu, M. F., & Lim, W. H. (2013). Phenytoin: A Guide to Therapeutic Drug Monitoring. Proceedings of Singapore Healthcare, 22(3), 198-202. https://doi.org/10.1177/201010581302200307
Vancouver
Wu MF, Lim WH. Phenytoin: A Guide to Therapeutic Drug Monitoring. Proceedings of Singapore Healthcare. 2013;22(3):198-202. doi:10.1177/201010581302200307
BibTeX
@article{Wu2013,
author = {Wu, Melissa Faye and Lim, Wai Hing},
title = {Phenytoin: A Guide to Therapeutic Drug Monitoring},
journal = {Proceedings of Singapore Healthcare},
year = {2013},
volume = {22},
number = {3},
pages = {198--202},
doi = {10.1177/201010581302200307}
}
EUVIMED